Compositions and methods for treatment of retinal degenerative diseases

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10682328
APP PUB NO 20170266146A1
SERIAL NO

15532116

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This disclosure relates to compositions for use in treatment of Alzheimer's Disease, and/or a ocular and retinal degenerative disease, such as age related macular degeneration. The described compositions include effective amounts of LLMe, the hydrobromide form thereof, or functional derivatives thereof. Methods of treatment of a retinal degenerative disease of Alzheimer's Disease using the described compositions are also provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MOR RESEARCH APPLICATIONS LTDISRAEL LA MATT GAN RAMAT-GAN TEL AVIV DISTRICT

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dvashi, Zeev Tel Aviv, IL 5 1
Pollack, Ayala Tel Aviv, IL 3 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Dec 16, 2027
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 16, 2031
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00